BayerT.S., and SmolkeC.D. (2005). Programmable ligand-controlled riboregulators of eukaryotic gene expression. Nat. Biotechnol., 23, 337–343.
2.
BouladF., WangX., QuJ., et al. (2014). Safe mobilization of CD34+ cells in adults with beta-thalassemia and validation of effective globin gene transfer for clinical investigation. Blood, 123, 1483–1486.
3.
CavazzanaM. (2014). Hematopoietic stem cell gene therapy: progress on the clinical front. Hum. Gene Ther., 25, 165–170.
4.
Cavazzana-CalvoM., Hacein-BeyS., De Saint BasileG., et al. (2000). Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science, 288, 669–672.
5.
Cavazzana-CalvoM., PayenE., NegreO., et al. (2010). Transfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemia. Nature, 467, 318–322.
6.
CoffinJ.M., HughesS.H., and VarmusH.E. (1997). The interactions of retroviruses and their hosts. In Retroviruses. CoffinJ.M., HughesS.H., and VarmusH.E., eds. (Cold Spring Harbor, New York, NY).
7.
ConeR.D., Weber-BenarousA., BaortoD., and MulliganR.C. (1987). Regulated expression of a complete human beta-globin gene encoded by a transmissible retrovirus vector. Mol. Cell Biol, 7, 887–897.
8.
DanosO., and MulliganR.C. (1988). Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc. Natl. Acad. Sci. USA, 85, 6460–6464.
9.
DranoffG., and MulliganR.C. (1994). Activities of granulocyte-macrophage colony-stimulating factor revealed by gene transfer and gene knockout studies. Stem Cells, 12Suppl 1, 173–182; discussion 182–184.
10.
DranoffG., JaffeeE., LazenbyA., et al. (1993). Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA, 90, 3539–3543.
11.
DzierzakE.A., PapayannopoulouT., and MulliganR.C. (1988). Lineage-specific expression of a human beta-globin gene in murine bone marrow transplant recipients reconstituted with retrovirus-transduced stem cells. Nature, 331, 35–41.
12.
FearonE.R., PardollD.M., ItayaT., et al. (1990). Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell, 60, 397–403.
13.
GoffS.P., and BergP. (1976). Construction of hybrid viruses containing SV40 and lambda phage DNA segments and their propagation in cultured monkey cells. Cell, 9, 695–705.
14.
GoodellM.A., BroseK., ParadisG., et al. (1996). Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med., 183, 1797–1806.
15.
GoodellM.A., Mckinney-FreemanS., and CamargoF.D. (2005). Isolation and characterization of side population cells. Methods Mol. Biol., 290, 343–352.
16.
GussoniE., SoneokaY., StricklandC.D., et al. (1999). Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature, 401, 390–394.
17.
JanuszeskiM.M., CannonP.M., ChenD., et al. (1997). Functional analysis of the cytoplasmic tail of Moloney murine leukemia virus envelope protein. J. Virol., 71, 3613–3619.
18.
JuneC.H. (2014). Toward synthetic biology with engineered T cells: a long journey just begun. Hum. Gene Ther., 25, 779–784.
19.
KleinC., NguyenD., LiuC.H., et al. (2003). Gene therapy for Wiskott-Aldrich syndrome: rescue of T-cell signaling and amelioration of colitis upon transplantation of retrovirally transduced hematopoietic stem cells in mice. Blood, 101, 2159–2166.
20.
KottonD.N., FabianA.J., and MulliganR.C. (2005). A novel stem-cell population in adult liver with potent hematopoietic-reconstitution activity. Blood, 106, 1574–1580.
21.
LemischkaI.R., RauletD.H., and MulliganR.C. (1986). Developmental potential and dynamic behavior of hematopoietic stem cells. Cell, 45, 917–927.
22.
LinialM., MedeirosE., and HaywardW.S. (1978). An avian oncovirus mutant (SE 21Q1b) deficient in genomic RNA: biological and biochemical characterization. Cell, 15, 1371–1381.
23.
MannR., MulliganR.C., and BaltimoreD. (1983). Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell, 33, 153–159.
24.
MertzJ.E., CarbonJ., HerzbergM., et al. (1975). Isolation and characterization of individual clones of simian virus 40 mutants containing deletions duplications and insertions in their DNA. Cold Spring Harb. Symp. Quant. Biol., 39Pt 1, 69–84.
MillerA.D., GarciaJ.V., Von SuhrN., et al. (1991). Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J. Virol., 65, 2220–2224.
27.
MorganJ.R., BarrandonY., GreenH., and MulliganR.C. (1987). Expression of an exogenous growth hormone gene by transplantable human epidermal cells. Science, 237, 1476–1479.
28.
MulliganR.C., and BergP. (1980). Expression of a bacterial gene in mammalian cells. Science, 209, 1422–1427.
29.
MulliganR.C., and BergP. (1981). Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase. Proc. Natl. Acad. Sci. USA, 78, 2072–2076.
30.
MulliganR.C., HowardB.H., and BergP. (1979). Synthesis of rabbit beta-globin in cultured monkey kidney cells following infection with a SV40 beta-globin recombinant genome. Nature, 277, 108–114.
31.
RothenbergE., DonoghueD.J., and BaltimoreD. (1978). Analysis of a 5′ leader sequence on murine leukemia virus 21S RNA: heteroduplex mapping with long reverse transcriptase products. Cell, 13, 435–451.
32.
RozenblattS., MulliganR.C., GoreckiM., et al. (1976). Direct biochemical mapping of eukaryotic viral DNA by means of a linked transcription-translation cell-free system. Proc. Natl. Acad. Sci. USA, 73, 2747–2751.
33.
SadelainM., WangC.H., AntoniouM., et al. (1995). Generation of a high-titer retroviral vector capable of expressing high levels of the human beta-globin gene. Proc. Natl. Acad. Sci. USA, 92, 6728–6732.
34.
SoukupG.A., and BreakerR.R. (1999). Engineering precision RNA molecular switches. Proc. Natl. Acad. Sci. USA, 96, 3584–3589.
35.
TabinC.J., HoffmannJ.W., GoffS.P., and WeinbergR.A. (1982). Adaptation of a retrovirus as a eucaryotic vector transmitting the herpes simplex virus thymidine kinase gene. Mol. Cell Biol., 2, 426–436.
36.
WatanabeS., and TeminH.M. (1983). Construction of a helper cell line for avian reticuloendotheliosis virus cloning vectors. Mol. Cell Biol., 3, 2241–2249.
37.
WeiC.M., GibsonM., SpearP.G., and ScolnickE.M. (1981). Construction and isolation of a transmissible retrovirus containing the src gene of Harvey murine sarcoma virus and the thymidine kinase gene of herpes simplex virus type 1. J. Virol., 39, 935–944.
38.
WilliamsD.A., LemischkaI.R., NathanD.G., and MulliganR.C. (1984). Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse. Nature, 310, 476–480.
39.
WilsonJ.M., JohnstonD.E., JeffersonD.M., and MulliganR.C. (1988). Correction of the genetic defect in hepatocytes from the Watanabe heritable hyperlipidemic rabbit. Proc. Natl. Acad. Sci. USA, 85, 4421–4425.
40.
WilsonJ.M., DanosO., GrossmanM., et al. (1990). Expression of human adenosine deaminase in mice reconstituted with retrovirus-transduced hematopoietic stem cells. Proc. Natl. Acad. Sci. USA, 87, 439–443.
41.
YenL., SvendsenJ., LeeJ.S., et al. (2004). Exogenous control of mammalian gene expression through modulation of RNA self-cleavage. Nature, 431, 471–476.
